Wahba IM Gadolinium and kidney disease: Should we still be cautious? , Clin J Am Soc Nephrol: 2025

Pennekamp A, Wahba I Importance of MAP reduction for AKI induction in type 1 cardiorenal syndrome , Am J Kidney Dis : 2023

Rudnick MR, Fay K, Wahba IM Fluid administration strategies for the prevention of contrast-associated acute kidney injury , Curr Opin Nephrol Hypertens, 31(5): 2022,414-424

Rudnick MR, Wahba IM, Leonberg-Yoo AK, Miskulin D, Litt HI Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review , Am J Kidney Dis, 4: 2021,517-528

Rudnick M, Wahba IM, Miskulin D Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced kidney disease , UpToDate: 2020- Current

Srinivasan V, Ahmad S, Aggarwal S, Wahba I, Huan Y COVID-19 infection patterns in an academic inner city dialysis unit , Journal of the American Society of Nephrology: 2020

Rudnick M, Wahba IM, Leonberg-Yoo A Use of Gadolinium-Based Contrast Agents in Patients with Severe Renal Impairment. Absence of Risk Versus Caution: A Nephrologist’s Perspective , Kidney360, 1(6): 2020,433-435

Fink JC, Joy MS, St Peter WL, Wahba IM; ASN Chronic Kidney Disease Advisory Group. Finding a common language for patient safety in CKD , Clin J Am Soc Nephrol, 7(4): 2012,689-95

Dadfarmay S, Wahba IM Acute kidney injury due to pulmonary embolism: The case for congestive kidney failure , Nephrol Dial Transplant Plus , 4: 2011,295-298

Wahba IM The renal consequences of obesity- What have we learned in recent years? , US Nephrology, 3(2): 2009,12-15